Strategies for the combination therapy of HIV infection.
Yarchoan
R
R
Clinical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Mitsuya
H
H
Broder
S
S
D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D014779:Virus Replication / Q000187:drug effects; D016047:Zalcitabine / Q000008:administration & dosage / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine; D016047:Zalcitabine; D000212:Acyclovir